LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Antibodies from 1918 Flu Survivors Protect Against the Virus

By LabMedica International staff writers
Posted on 28 Aug 2008
Print article
A team of immunologists and virologists has successfully recovered immune system B cells from survivors of the 1918 influenza pandemic and used them to prepare monoclonal antibodies that provided protection against infection with the virus.

Investigators at Vanderbilt University (Nashville, TN, USA) collected blood samples from 32 survivors of the 1918 pandemic now aged from 91-101 years. Sera from all the survivors demonstrated positive immune responses to the 1918 virus, suggesting that they still possessed antibodies to the virus.

A subset of seven donor samples tested had circulating B cells that secreted antibodies that bound the 1918 haemagglutinin (HA) protein antigen. The investigators isolated B cells from these subjects and generated five monoclonal antibodies that showed potent neutralizing activity against the 1918 virus from three separate donors. These antibodies also cross-reacted with the genetically similar HA of a 1930 swine H1N1 influenza strain, but did not cross-react with HAs of more contemporary human influenza viruses. The antibodies bound to the 1918 HA protein with high affinity, had exceptional virus-neutralizing potency, and protected mice from lethal infection.

"The B cells have been waiting for at least 60 years – if not 90 years – for that flu to come around again,” said senior author Dr. James Crowe, professor of pediatrics at Vanderbilt University. "That is amazing…because it is the longest memory anyone's ever demonstrated. The lessons we are learning about the 1918 flu tell us a lot about what may happen during a future pandemic.”

The investigators concluded their paper in the August 17, 2008, online edition of the journal Nature with the observation: "These studies demonstrate that survivors of the 1918 influenza pandemic possess highly functional, virus-neutralizing antibodies to this uniquely virulent virus, and that humans can sustain circulating B memory cells to viruses for many decades after exposure—well into the tenth decade of life.”

Related Links:
Vanderbilt University

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: The AI predictive model identifies the most potent cancer killing immune cells for use in immunotherapies (Photo courtesy of Shutterstock)

AI Predicts Tumor-Killing Cells with High Accuracy

Cellular immunotherapy involves extracting immune cells from a patient's tumor, potentially enhancing their cancer-fighting capabilities through engineering, and then expanding and reintroducing them into the body.... Read more

Microbiology

view channel
Image: The T-SPOT.TB test is now paired with the Auto-Pure 2400 liquid handling platform for accurate TB testing (Photo courtesy of Shutterstock)

Integrated Solution Ushers New Era of Automated Tuberculosis Testing

Tuberculosis (TB) is responsible for 1.3 million deaths every year, positioning it as one of the top killers globally due to a single infectious agent. In 2022, around 10.6 million people were diagnosed... Read more